Barclays Cuts RXO (NYSE:RXO) Price Target to $30.00

RXO (NYSE:RXOFree Report) had its price target lowered by Barclays from $32.00 to $30.00 in a report issued on Friday,Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other research firms also recently commented on RXO. Susquehanna cut their price objective on shares of RXO from $16.00 to $12.00 and set a “negative” rating for the company in a report on Tuesday, November 12th. Jefferies Financial Group reduced their price objective on RXO from $33.00 to $30.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. Citigroup cut RXO from a “buy” rating to a “neutral” rating and set a $33.00 target price for the company. in a report on Tuesday, November 12th. Benchmark reaffirmed a “hold” rating on shares of RXO in a research note on Wednesday, January 15th. Finally, Wells Fargo & Company dropped their price target on shares of RXO from $31.00 to $28.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 7th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, RXO presently has a consensus rating of “Hold” and a consensus target price of $26.77.

Check Out Our Latest Stock Analysis on RXO

RXO Stock Performance

NYSE:RXO opened at $25.18 on Friday. RXO has a fifty-two week low of $18.75 and a fifty-two week high of $32.82. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.33 and a current ratio of 1.33. The company has a fifty day moving average of $26.73 and a two-hundred day moving average of $27.79. The stock has a market capitalization of $4.05 billion, a PE ratio of -12.72, a P/E/G ratio of 3.17 and a beta of 1.52.

RXO (NYSE:RXOGet Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.04 by $0.01. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. The firm had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $956.19 million. During the same period in the prior year, the company earned $0.05 EPS. The firm’s revenue was up 6.6% compared to the same quarter last year. As a group, research analysts forecast that RXO will post 0.11 earnings per share for the current fiscal year.

Hedge Funds Weigh In On RXO

Several institutional investors have recently bought and sold shares of the company. Wilmington Savings Fund Society FSB purchased a new position in shares of RXO in the third quarter valued at approximately $28,000. Nomura Asset Management Co. Ltd. boosted its position in RXO by 68.7% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock valued at $39,000 after buying an additional 570 shares during the period. Thurston Springer Miller Herd & Titak Inc. grew its stake in shares of RXO by 407.0% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company’s stock worth $43,000 after acquiring an additional 1,445 shares in the last quarter. GAMMA Investing LLC increased its position in shares of RXO by 40.0% during the third quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock worth $50,000 after acquiring an additional 510 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new stake in shares of RXO in the second quarter valued at $112,000. 92.73% of the stock is owned by institutional investors and hedge funds.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.